Regeneron Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US75886F1075

SecurityREGN / Regeneron Pharmaceuticals, Inc.
InstitutionNEXT Financial Group, Inc
Latest Disclosed Ownership3,480 shares
Latest Disclosed Value $ 2,198,000
NEXT Financial Group, Inc reports 40.66% increase in ownership of REGN / Regeneron Pharmaceuticals, Inc.

On February 15, 2022 - NEXT Financial Group, Inc filed a 13F-HR form disclosing ownership of 3,480 shares of Regeneron Pharmaceuticals, Inc. (US:REGN) valued at $2,197,690 USD as of December 31, 2021. The entity filed a previous 13F-HR on October 15, 2021 disclosing 2,474 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 40.66% during the quarter. The current value of the position is $2,211,366 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2022-02-15 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 3,480 1,006 40.66 2,198 46.83 0.1445
2021-10-15 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 2,474 -238 -8.78 1,497 -1.12 0.1168
2021-07-13 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 2,712 -14 -0.51 1,514 17.36 0.1212
2021-04-16 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,726 638 30.56 1,290 27.85 0.1146
2021-02-05 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 2,088 722 52.86 1,009 32.07 0.0966
2020-10-22 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 1,366 1,366 764 0.0822
2020-07-23 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -195 -100.00 0 -100.00
2020-04-27 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 195 173 786.36 95 1,087.50 0.0122
2020-01-21 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 22 -3 -12.00 8 14.29 0.0008
2019-10-17 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 25 0 0.00 7 -12.50 0.0008
2019-07-16 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 25 -500 -95.24 8 -96.30 0.0009
2019-07-16 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 525 500 2,000.00 216 2,300.00 0.0547
2019-02-11 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 25 25 9 0.0019
2018-01-16 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -495 -100.00 0 -100.00
2017-11-08 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 495 -340 -40.72 219 -46.59 0.0610
2017-07-12 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 835 -81 -8.84 410 15.17 0.1002
2017-05-08 2017-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 916 21 2.35 356 8.21 0.0991
2017-02-02 2016-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 895 535 148.61 329 126.90 0.0578
2016-11-01 2016-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 360 115 46.94 145 70.59 0.0262
2016-07-07 2016-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 245 135 122.73 85 117.95 0.0270
2016-04-20 2016-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 110 100 1,000.00 39 680.00 0.0137
2016-02-02 2015-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 10 0 0.00 5 25.00 0.0019
2016-02-02 2015-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 10 5
2015-10-20 2015-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 10 10 0.00 4 0.0014
2015-02-10 2014-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -28 -100.00 0 -100.00
2015-02-10 2014-09-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 28 28 10 0.0020
2014-10-23 2014-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 28 10
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.